{"status":"OK","data":{"advertisement":{"id":210230,"title":"ZAPYTANIE OFERTOWE (RFQ) nr. 25/2023/G/STEP7","partial_offer_allowed":false,"publication_date":"2023-05-29","submission_deadline":"2023-06-06 23:59:59","planned_sign_date":"2023-06-01","supplementary_orders":null,"terms_of_contract_change":null,"created_at":"2023-05-29 14:44:34","modified_at":"2023-06-07 00:00:03","contact_persons":[{"id":64,"forename":"Paulina","surname":"Gruszka","phone_number":"","email":"paulina.gruszka@celonpharma.com","created_by":null,"created_at":"2025-05-14 12:08:24","modified_at":"2025-05-14 12:08:24","modified_by":null}],"orders":[{"id":346762,"estimated_value":null,"order_items":[{"id":392630,"description":"Przeprowadzenie nast\u0119puj\u0105cego programu bada\u0144 do realizacji Projektu w ramach podwykonawstwa:\n\n- Przeprowadzenie badania maksymalnej tolerowanej dawki u myszy z zastosowaniem doustnej drogi podania.\n\n Dodatkowe informacje:\n\uf02d\tZamawiaj\u0105cy deklaruje gotowo\u015b\u0107 rozpocz\u0119cia realizacji programu badawczego okre\u015blonego w niniejszym dokumencie od drugiej po\u0142owy lipca 2023r.,\n\uf02d\tPlanowany program bada\u0144 b\u0119dzie prowadzony w standardzie non-GLP,\n\uf02d\tPlanowany program bada\u0144 b\u0119dzie prowadzony zgodnie z wytycznymi naukowymi Europejskiej Agencji Lek\u00f3w dotycz\u0105cymi nieklinicznego badania lek\u00f3w,\n\uf02d\tJ\u0119zyk angielski musi by\u0107 u\u017cywany we wszystkich celach zwi\u0105zanych z przygotowywaniem dokument\u00f3w i sprawozdawczo\u015bci\u0105.","warranty_period":null,"cpv_items":[{"id":8513,"code":"73100000-3","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"mazowieckie","poviat":"nowodworski","commune":"Czosn\u00f3w","locality":"Kazu\u0144 Nowy","created_by":null,"created_at":"2023-05-29 14:44:34","modified_at":"2023-05-29 14:44:34","modified_by":null,"id":442103,"type":{"id":1,"name":"adres"},"group_uuid":"403173cb-1a22-4819-837a-0807b5fca4a2"}],"participation_conditions":[],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-05-29 14:44:34","modified_at":"2023-05-29 14:44:34","modified_by":null,"group_uuid":"52777ce8-6b87-4830-897c-e080d1a5fb0b"}],"evaluation_criteria":[{"id":600259,"price_criterion":true,"description":"Cena \u201eP\u201d \u2013 70 punkt\u00f3w (70% maksymalnej liczby punkt\u00f3w do zdobycia)","created_by":null,"created_at":"2023-05-29 14:44:34","modified_at":"2023-05-29 14:44:34","modified_by":null,"group_uuid":"b1b0bf43-8c5e-4029-8a70-c74432f2ab00"},{"id":600260,"price_criterion":false,"description":"Data rozpocz\u0119cia badania \u201eT1\u201d \u2013 15 punkt\u00f3w (15% maksymalnej liczby punkt\u00f3w do zdobycia)","created_by":null,"created_at":"2023-05-29 14:44:34","modified_at":"2023-05-29 14:44:34","modified_by":null,"group_uuid":"3e88fa69-c211-43ed-8964-d98a4671febd"},{"id":600261,"price_criterion":false,"description":"Termin uko\u0144czenia badania \u201eT2\u201d \u2013 15 punkt\u00f3w (jest to 15% maksymalnej liczby punkt\u00f3w do zdobycia)","created_by":null,"created_at":"2023-05-29 14:44:34","modified_at":"2023-05-29 14:44:34","modified_by":null,"group_uuid":"54fe1221-4128-4209-a9d6-a682277af7a9"}],"is_variant":false,"title":"Przeprowadzenie badania","order_node":{"id":263698},"created_by":null,"created_at":"2023-05-29 14:44:34","modified_at":"2023-05-29 14:44:34","modified_by":null}],"created_by":{"id":177,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Celon Pharma S.A.","identification_number_type":"nip","identification_number":"1181642061","address":{"country":"Polska","voivodeship":"mazowieckie","poviat":"warszawski zachodni","commune":"\u0141omianki","locality":"Kie\u0142pin","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":549015,"street":"Ogrodowa ","number_description":"2A","postcode":"05-092"},"created_by":{"id":177,"contact_persons":[]},"created_at":"2023-05-29 14:44:34","modified_at":"2023-05-29 14:44:34","modified_by":{"id":177,"contact_persons":[]},"id":210708},"advertisement":{"id":160375,"number":"2023-177-160375","publication_date":"2023-05-29","created_by":{"id":177,"contact_persons":[]},"created_at":"2023-05-29 14:44:34","modified_at":"2023-06-07 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[210230],"enrollment":null,"projects":[{"id":656,"name":"Serotoninergiczna terapia przeciwb\u00f3lowa oparta o agonist\u0119 receptora 5-HT7 (STEP7)","number":"0887/19","activity":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"region":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2022-02-10 21:45:42","modified_at":"2022-02-10 21:45:42","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"institution":null,"full_number":"POIR.01.01.01-00-0887/19","perspective":{},"programme":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"type":"project","created_by":{"id":177,"contact_persons":[]},"created_at":"2020-08-19 14:14:32","modified_at":"2020-08-19 14:14:32","modified_by":{"id":177,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":210230,"publication_date":"2023-05-29"},"id":1020781,"name":"Zapytanie ofertowe","file":{"id":1137519,"name":"ZO_25_2023_G_STEP7.pdf","created_at":"2023-05-29 14:44:09","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1137519"},"group_uuid":"eb49679d-454a-4710-9245-8b3fd2ed5f81"},{"origin":{"id":210230,"publication_date":"2023-05-29"},"id":1020782,"name":"O\u015bwiadczenie","file":{"id":1137521,"name":"zal. 1 Oswiadczenie o braku powiazan.pdf","created_at":"2023-05-29 14:44:17","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1137521"},"group_uuid":"315a69de-bfe4-41db-b862-0e5fe9da9960"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}